Revenues of TEVA PHARMACEUTICAL INDUSTRIES LTD for 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: TEVA PHARMACEUTICAL INDUSTRIES LTD quarterly Revenues in USD history and change rate for 31 Dec 2025.
TEVA PHARMACEUTICAL INDUSTRIES LTD Revenues for the quarter ending 31 Dec 2025 was $1,500,000,000.
Source SEC data: View on sec.gov

Revenues, Quarterly (USD)

TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Revenues (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025		$1,500,000,000			01 Oct 2025	31 Dec 2025	10-K	03 Feb 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.